Expression of tumour-specific antigens underlies cancer immunoediting
暂无分享,去创建一个
T. Jacks | Michel DuPage | Tyler Jacks | Michel DuPage | Claire Mazumdar | Leah M. Schmidt | Ann F. Cheung | L. Schmidt | A. Cheung | Claire Mazumdar
[1] T. Jacks,et al. Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression. , 2011, Cancer cell.
[2] J. Shabanowitz,et al. The Immunodominant Antigen of an Ultraviolet-induced Regressor Tumor Is Generated by a Somatic Point Mutation in the DEAD Box Helicase p68 , 1997, The Journal of experimental medicine.
[3] Yao-Tseng Chen,et al. The SSX gene family: Characterization of 9 complete genes , 2002, International journal of cancer.
[4] David Jones,et al. A personal view , 1992, Nature.
[5] C. Uyttenhove,et al. Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression , 1983, The Journal of experimental medicine.
[6] T. Jacks,et al. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase , 2009, Nature Protocols.
[7] T. Blankenstein,et al. A cancer immunosurveillance controversy , 2004, Nature Immunology.
[8] R. Prehn,et al. Immunity to methylcholanthrene-induced sarcomas. , 1957, Journal of the National Cancer Institute.
[9] N. Greenberg,et al. NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy (DOI:10.1016/j.immuni.2008.02.016) , 2008 .
[10] K. Irvine,et al. De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model. , 2006, Cancer research.
[11] G. Willimsky,et al. Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance , 2005, Nature.
[12] L. Zitvogel,et al. Cancer despite immunosurveillance: immunoselection and immunosubversion , 2006, Nature Reviews Immunology.
[13] H. Levitsky,et al. Reciprocal Changes in Tumor Antigenicity and Antigen-specific T Cell Function during Tumor Progression , 2004, The Journal of experimental medicine.
[14] E. Mardis,et al. Cancer Exome Analysis Reveals a T Cell Dependent Mechanism of Cancer Immunoediting , 2012, Nature.
[15] Robert A. Weinberg,et al. Comparative Biology of Mouse versus Human Cells: Modelling Human Cancer in Mice O P I N I O N , 2022 .
[16] R. Schreiber,et al. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.
[17] N. Greenberg,et al. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. , 2008, Immunity.
[18] R. Vile. Faculty Opinions recommendation of IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. , 2001 .
[19] R. Schreiber,et al. Cancer immunoediting: from immunosurveillance to tumor escape , 2002, Nature Immunology.
[20] C. Heidelberger,et al. Antigenicity of clones of mouse prostate cells transformed in vitro , 1972, International journal of cancer.
[21] O. Scott. Tumor transplantation and tumor immunity: a personal view. , 1991, Cancer research.
[22] P. Monach,et al. A unique tumor antigen produced by a single amino acid substitution. , 1995, Immunity.
[23] T. Jacks,et al. Regulated expression of a tumor-associated antigen reveals multiple levels of T-cell tolerance in a mouse model of lung cancer. , 2008, Cancer research.
[24] C. Van Waes,et al. Identification of a unique tumor antigen as rejection antigen by molecular cloning and gene transfer , 1986, The Journal of experimental medicine.
[25] Jan Grimm,et al. A spatially and temporally restricted mouse model of soft tissue sarcoma , 2007, Nature Medicine.
[26] H. Hewitt,et al. A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin. , 1976, British Journal of Cancer.
[27] N. Restifo,et al. Natural selection of tumor variants in the generation of “tumor escape” phenotypes , 2002, Nature Immunology.
[28] Lloyd J. Old,et al. Adaptive immunity maintains occult cancer in an equilibrium state , 2007, Nature.
[29] P. Azadi,et al. A Mutant Chaperone Converts a Wild-Type Protein into a Tumor-Specific Antigen , 2006, Science.
[30] S. Akira,et al. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis , 2008, Proceedings of the National Academy of Sciences.